Dr. Agarwal’s Health Care Limited delivered a strong performance for FY2026, with total income soaring by 20.9% year-on-year to ₹2,125 crores. The company’s expansion strategy reached a milestone with 288 facilities operational across 10 countries. Growth was supported by a 22.2% increase in EBITDA to ₹614 crores and a significant 52.4% rise in Profit After Tax to ₹168 crores, reflecting the company’s commitment to operational efficiency and clinical excellence.
Fiscal Performance Highlights
The company achieved a landmark fiscal year in 2026, crossing ₹2,000 crores in revenue from operations for the first time. For the twelve months ended March 31, 2026, total income reached ₹2,125 crores, marking a 20.9% growth over the previous year. Profitability also improved substantially, with Profit After Tax (PAT) climbing to ₹168 crores, a significant 52.4% increase year-on-year, and EBITDA rising to ₹614 crores with margins at 28.9%.
For the fourth quarter (January–March 2026), the company reported total income of ₹577 crores, up 21.2%, and performed 84,962 surgeries, demonstrating strong operational momentum.
Strategic Network Expansion
Dr. Agarwal’s Health Care expanded its footprint aggressively, commissioning 57 new facilities throughout the year, averaging one new center every week. This brought the total network to 288 facilities across 10 countries. Notably, 30 of these new additions were surgical centers, further strengthening clinical capacity. A key highlight of the year was the successful entry into the Delhi NCR region, where six facilities were made operational within twelve months.
Resource Reallocation
Following the successful completion of the Initial Public Offering, the company has strategically reallocated unutilized funds originally designated for ‘Issue Related Expenses’. These funds are now directed toward ‘General Corporate Purposes and Unidentified Inorganic Acquisitions’. This shift is designed to provide a robust liquidity buffer, supporting the scaling of existing operations and enabling the company to effectively manage future contingencies and growth opportunities.
Source: BSE
